77 related articles for article (PubMed ID: 344103)
1. Clinical trial with Corynebacterium parvum.
Medenica R; Girard JP; Maurice P
Dev Biol Stand; 1977 Apr 13-15; 38():483-5. PubMed ID: 344103
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies with Corynebacterium parvum.
Mitcheson HD; Castro JE
Dev Biol Stand; 1977 Apr 13-15; 38():509-14. PubMed ID: 344105
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
Bast RC; Berek JS; Obrist R; Griffiths CT; Berkowitz RS; Hacker NF; Parker L; Lagasse LD; Knapp RC
Cancer Res; 1983 Mar; 43(3):1395-401. PubMed ID: 6825108
[TBL] [Abstract][Full Text] [Related]
4. Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.
Lichtenstein A; Berek J; Bast R; Spina C; Hacker N; Knapp RC; Zighelboim J
J Biol Response Mod; 1984 Aug; 3(4):371-8. PubMed ID: 6541243
[TBL] [Abstract][Full Text] [Related]
5. Toxic and immunologic side effects of daily C. parvum-infusion in treatment-resistant cancer patients.
Mayr AC; Westerhausen M; Senn HJ
Dev Biol Stand; 1977 Apr 13-15; 38():523-7. PubMed ID: 608546
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of Corynebacterium parvum on lymphocyte transformation.
Fisher RA
Dev Biol Stand; 1977 Apr 13-15; 38():461-6. PubMed ID: 608539
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumour C. parvum therapy in gastric carcinoma; a pilot study.
Dykes PW; Trejdosiewicz LK
Dev Biol Stand; 1977 Apr 13-15; 38():547-52. PubMed ID: 608548
[TBL] [Abstract][Full Text] [Related]
8. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of a multi-modal schedule with Corynebacterium parvum.
McIntosh IH; Thynne GS; Bejrajati P; Walsh G; Greening WP
Dev Biol Stand; 1977 Apr 13-15; 38():477-82. PubMed ID: 344102
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial in advanced breast cancer using combination chemotherapy with or without C. parvum; preliminary results.
Mayr AC; Senn HJ; Gallmeier WM; Drings P; Queisser W
Dev Biol Stand; 1977 Apr 13-15; 38():553-7. PubMed ID: 344108
[TBL] [Abstract][Full Text] [Related]
11. A survey of patients' reactions to intravenous Corynebacterium parvum therapy.
Palmer BV; Walsh G; Smedley P; McIntosh IH; Greening WP
Dev Biol Stand; 1977 Apr 13-15; 38():529-33. PubMed ID: 608547
[TBL] [Abstract][Full Text] [Related]
12. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
13. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
Thatcher N; Crowther D
Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
[TBL] [Abstract][Full Text] [Related]
14. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
Webster DJ; Chare MJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast.
Chare MJ; Webster DJ; Baum M
Dev Biol Stand; 1977 Apr 13-15; 38():495-9. PubMed ID: 344104
[TBL] [Abstract][Full Text] [Related]
17. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
18. The complications of intravenous Corynebacterium parvum infusion.
Gill PG; Morris PJ; Kettlewell M
Clin Exp Immunol; 1977 Nov; 30(2):229-32. PubMed ID: 606444
[TBL] [Abstract][Full Text] [Related]
19. Corynebacterium parvum in malignant pleural effusion. A randomized prospective study.
Hillerdal G; Kiviloog J; Nöu E; Steinholtz L
Eur J Respir Dis; 1986 Sep; 69(3):204-6. PubMed ID: 2430825
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
